The relationship between growth hormone (GH) messenger ribonucleic acid levels and hormone release from individual cells derived from human GH‐secreting pituitary adenomas
- 1 January 1991
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 34 (1), 5-11
- https://doi.org/10.1111/j.1365-2265.1991.tb01728.x
Abstract
GH mRNA expression and GH release by Individual cells derived from four GH‐secreting pituitary adenomas were studied by in‐situ hybridization and the reverse haemolytic plaque assay, respectively. In addition the percentage of PRL mRNA‐containing cells was determined in these cell suspensions. The percentages of GH mRNA‐containing cells varied between 52 and 89 while the percentages of GH plaque forming cells varied between 25 and 77. Frequency distributions of GH mRNA levels in individual cells and of individual GH plaque areas showed a majority of the cells having low GH mRNA levels and secreting low amounts of GH respectively, while there is a low proportion of cells expressing high GH mRNA levels and forming large GH plaques. There was a significant correlation between the GH mRNA levels and the GH plaque areas of individual cells from the four adenomas (P > 0.001). The percentages of PRL mRNA‐containing cells in the four different adenomas amounted to > 1, 5, 2 and 18. Cultured cells from the adenomas consisting of 5 and 18|X% PRL mRNA‐containing cells also contained and released measurable amounts of PRL. Our data show that Individual cells from GH‐secreting pituitary adenomas are heterogeneous with respect to GH mRNA expression, a small proportion of the cells expressing a high amount of GH mRNA. The heterogeneity in GH mRNA expression is correlated with the heterogeneity In GH release. These observations suggest that a considerable part of GH secreted from a GH‐secreting pituitary adenoma is produced by a minority of the GH‐secreting tumour cell population. This might be a basis for the disappointing degree of tumour shrinkage which is observed in most acromegalic patients treated with the somatostatin analogue SMS 201–995.Keywords
This publication has 18 references indexed in Scilit:
- Regulation of Growth Hormone Secretion and Messenger Ribonucleic Acid Accumulation in Human Somatotropinoma Cellsin Vitro*Journal of Clinical Endocrinology & Metabolism, 1989
- GLYCOPROTEIN HORMONE ALPHA‐SUBUNIT AND PROLACTIN RELEASE BY CULTURED PITUITARY ADENOMA CELLS FROM ACROMEGALIC PATIENTS: CORRELATION WITH GH RELEASEClinical Endocrinology, 1989
- Heterogeneity of Growth Hormone (GH) Release by Individual Pituitary Adenoma Cells From Acromegalic Patients, as Determined by the Reverse Hemolytic Plaque Assay: Effects of SMS 201-995, GH-Releasing Hormone and Thyrotropin-Releasing Hormone*Journal of Clinical Endocrinology & Metabolism, 1989
- Discrepancy between Prolactin (PRL) Messenger Ribonucleic Acid and PRL Content in Rat Fetal Pituitary Cells: Possible Role of DopamineMolecular Endocrinology, 1988
- Quantitative in-situ hybridization histochemistry studies on growth hormone (GH) gene expression in acromegalic somatotrophs: effects of somatostatin, GH-releasing factor and cortisolJournal of Molecular Endocrinology, 1988
- Glucocorticoid Stimulation of Growth Hormone Messenger Ribonucleic Acid Levels in GH 3 Cells Is Inhibited by Calcium But Not by Somatostatin*Endocrinology, 1987
- Effects of Hypophysiotropic Factors on Growth Hormone and Prolactin Secretion from Somatotroph Adenomas in CultureJournal of Clinical Endocrinology & Metabolism, 1985
- Pathophysiology of Acromegaly*Endocrine Reviews, 1983
- Comparative Study of Human Fetal, Normal Adult, and Somatotropic Adenoma Pituitary Function in Tissue Culture*Journal of Clinical Endocrinology & Metabolism, 1982
- Human Growth Hormone: Complementary DNA Cloning and Expression in BacteriaScience, 1979